Abstract
In this issue of Blood, Li et al report mutations in the 3' untranslated region (3'UTR) of TP53 that modify the expression of p53 and thus its effect on response to therapy in diffuse large B-cell lymphoma (DLBCL) patients.
Cite
CITATION STYLE
APA
Jardin, F., & Coiffier, B. (2013, May 30). TP53 and outcome in DLBCL: not only the coding region. Blood. https://doi.org/10.1182/blood-2013-04-493486
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free